Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design.
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Dempster J, Fraenkel MB, Harris A, Harris DC, Johnson DW, Kesselhut J, Luxton G, Pilmore A, Pollock CA, Tiller DJ; IDEAL Study Steering Committee. Cooper BA, et al. Among authors: fraenkel mb. Perit Dial Int. 2004 Mar-Apr;24(2):176-81. Perit Dial Int. 2004. PMID: 15119639 Clinical Trial.
A randomized, controlled trial of early versus late initiation of dialysis.
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA; IDEAL Study. Cooper BA, et al. Among authors: fraenkel mb. N Engl J Med. 2010 Aug 12;363(7):609-19. doi: 10.1056/NEJMoa1000552. Epub 2010 Jun 27. N Engl J Med. 2010. PMID: 20581422 Free article. Clinical Trial.
Cost-effectiveness of initiating dialysis early: a randomized controlled trial.
Harris A, Cooper BA, Li JJ, Bulfone L, Branley P, Collins JF, Craig JC, Fraenkel MB, Johnson DW, Kesselhut J, Luxton G, Pilmore A, Rosevear M, Tiller DJ, Pollock CA, Harris DC. Harris A, et al. Among authors: fraenkel mb. Am J Kidney Dis. 2011 May;57(5):707-15. doi: 10.1053/j.ajkd.2010.12.018. Epub 2011 Feb 23. Am J Kidney Dis. 2011. PMID: 21349618 Clinical Trial.
Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the IDEAL trial.
Johnson DW, Wong MG, Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA. Johnson DW, et al. Among authors: fraenkel mb. Perit Dial Int. 2012 Nov-Dec;32(6):595-604. doi: 10.3747/pdi.2012.00046. Perit Dial Int. 2012. PMID: 23212859 Free PMC article. Clinical Trial.
Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial.
Collins J, Cooper B, Branley P, Bulfone L, Craig J, Fraenkel M, Harris A, Johnson D, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller D, Harris D, Pollock C. Collins J, et al. Contrib Nephrol. 2011;171:1-9. doi: 10.1159/000327146. Epub 2011 May 23. Contrib Nephrol. 2011. PMID: 21625083 Clinical Trial.
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.
Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ. Zoungas S, et al. J Am Coll Cardiol. 2006 Mar 21;47(6):1108-16. doi: 10.1016/j.jacc.2005.10.064. Epub 2006 Feb 23. J Am Coll Cardiol. 2006. PMID: 16545638 Free article. Clinical Trial.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
24 results